Prostate cancer is a rapidly expanding area for radiopharmaceutical therapy, primarily driven by prostate-specific membrane antigen-targeted imaging and therapy. This growth necessitates new workflows that address the full clinical spectrum of care. This artic... ...

请注册登录后继续浏览